Open AccessP1358: WILL COVID‐19 PANDEMIC CHANGE MOBILIZATION STRATEGY OF HEMATOPOIETIC STEM CELLS IN MULTIPLE MYELOMA PATIENTS FOR THE BETTER?
Author(s) -
Marques B.,
Roque A.,
Ruzickova L.,
Carda J. P.,
Gomes M.,
Sarmento Ribeiro A. B.,
Geraldes C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848296.28542.2d
Subject(s) - plerixafor , medicine , multiple myeloma , apheresis , cd34 , granulocyte colony stimulating factor , oncology , mobilization , hematopoietic stem cell transplantation , cyclophosphamide , autologous stem cell transplantation , stem cell , transplantation , cxcr4 , surgery , chemotherapy , platelet , biology , history , chemokine , receptor , archaeology , genetics